Literature DB >> 3111089

Tri(n-butyl) phosphate/detergent treatment of licensed therapeutic and experimental blood derivatives.

C A Edwards, M P Piet, S Chin, B Horowitz.   

Abstract

Incubation of an AHF concentrate with 0.3% tri(n-butyl)phosphate (TNBP) and 0.2% sodium cholate was shown to inactivate at least 10,000 infectious doses of lipid-enveloped viruses, including hepatitis B and non-A, non-B viruses and HTLV-III [Prince et al., Lancet i, pp. 706-710, 1986]. The use of TNBP/detergent combinations for virus sterilization was evaluated further to determine its effect on the structure and function of a wide variety of blood proteins. Vesicular stomatitis and Sindbis viruses were used as markers of virus inactivation. TNBP/detergent treatment did not significantly alter the function of AHF, factor VII, factor IX, factor X, fibrinogen, factor XIII, fibronectin, anti-HBsAg and anti-HA in normal serum globulin, haptoglobin, tumor necrosis factor, alpha-interferon, and both native and chemically polymerized stroma-free hemoglobin. As compared with partially purified derivatives, the extent of virus sterilization of plasma and component cryoprecipitate with 0.3% TNBP and 0.2% sodium cholate at ambient temperature could be improved by raising the TNBP concentration and temperature. Virus sterilization by TNBP/detergent mixtures appears to be generally applicable to blood protein derivatives.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3111089     DOI: 10.1111/j.1423-0410.1987.tb02989.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  5 in total

1.  No evidence for neoantigens in human plasma after photochemical virus inactivation.

Authors:  H Mohr; J Knüver-Hopf; B Lambrecht; H Scheidecker; H Schmitt
Journal:  Ann Hematol       Date:  1992-11       Impact factor: 3.673

2.  Update: Intravenous immune globulin in children.

Authors: 
Journal:  Can J Infect Dis       Date:  1995-01

3.  Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV.

Authors:  A M Prince; B Horowitz; L Baker; R W Shulman; H Ralph; J Valinsky; A Cundell; B Brotman; W Boehle; F Rey
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

4.  Separation of antihemophilic factor VII from human plasma by column chromatography.

Authors:  V M Baikar; M V Kamath; C Vishwanathan; A M Varadkar; S E Bharmal
Journal:  Indian J Clin Biochem       Date:  2003-01

5.  Purification of severe acute respiratory syndrome hyperimmune globulins for intravenous injection from convalescent plasma.

Authors:  Zhan Zhang; Yi-Wu Xie; Jiling Hong; Xin Zhang; Sui Yi Kwok; Xiaowu Huang; Sai Wah Wong; Bing-Lou Wong
Journal:  Transfusion       Date:  2005-07       Impact factor: 3.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.